EP 1565468 A1 20050824 - NOVEL XANTHIN DERIVATIVES, PRODUCTION AND USE THEREOF AS MEDICAMENTS
Title (en)
NOVEL XANTHIN DERIVATIVES, PRODUCTION AND USE THEREOF AS MEDICAMENTS
Title (de)
NEUE XANTHINDERIVATE, DEREN HERSTELLUNG UND DEREN VERWENDUNG ALS ARZNEIMITTEL
Title (fr)
DERIVES DE XANTHINE, LEUR PRODUCTION ET LEUR UTILISATION EN TANT QUE MEDICAMENTS
Publication
Application
Priority
- DE 10254304 A 20021121
- EP 0312821 W 20031117
Abstract (en)
[origin: WO2004046148A1] The invention relates to substituted xanthins of general formula (I) wherein R1 - R4 are defined as in Claim 1, the tautomers thereof, the stereoisomers thereof, the mixtures thereof, the prodrugs and salts thereof which exhibit valuable pharmacological properties, especially an inhibitive effect on the activity of the enzyme Dipeptidylpeptidase-IV (DPP-IV).
IPC 1-7
IPC 8 full level
A61P 3/10 (2006.01); C07D 473/04 (2006.01); C07D 473/06 (2006.01); C07D 473/08 (2006.01)
CPC (source: EP US)
A61P 3/04 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 19/10 (2017.12 - EP); A61P 37/06 (2017.12 - EP); C07D 473/04 (2013.01 - EP US); C07D 473/06 (2013.01 - EP US); C07D 473/08 (2013.01 - EP US)
Citation (search report)
See references of WO 2004046148A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2004046148 A1 20040603; WO 2004046148 A8 20050714; AU 2003289872 A1 20040615; AU 2003289872 A8 20040615; CA 2506720 A1 20040603; DE 10254304 A1 20040603; EP 1565468 A1 20050824; JP 2006508969 A 20060316; US 2004138215 A1 20040715; US 7560450 B2 20090714
DOCDB simple family (application)
EP 0312821 W 20031117; AU 2003289872 A 20031111; CA 2506720 A 20031117; DE 10254304 A 20021121; EP 03782204 A 20031111; JP 2004552618 A 20031117; US 71614103 A 20031118